FAB:NSD-First Trust Multi Cap Value AlphaDEX Fund (USD)

ETF | Mid-Cap Value | NASDAQ Global Market

Last Closing

USD 81.9418

Change

+1.65 (+2.06)%

Market Cap

USD 0.11B

Volume

4.29K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq AlphaDEX(R) Multi Cap Value Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select value stocks from the NASDAQ US 500 Large Cap Index, NASDAQ US 600 Mid Cap Index and NASDAQ US 700 Small Cap Index that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX(R) selection methodology.

Inception Date: 08/05/2007

Primary Benchmark: NASDAQ AlphaDEX(R) Multi-C Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.68%

Management Expense Ratio: 0.70 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 0.49 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Mid-Cap Value

Symbol Name Mer Price(Change) Market Cap
SDVY First Trust SMID Cap Rising Di.. 0.60 %

+0.02 (+0.06%)

USD 3.41B
PEY Invesco High Yield Equity Divi.. 0.53 %

-0.01 (-0.05%)

USD 1.20B
JKI iShares Morningstar Mid-Cap Va.. 0.30 %

N/A

USD 0.41B
PY Principal Value ETF 0.29 %

+0.03 (+0.08%)

USD 0.06B
DDIV First Trust RBA Quality Income 0.69 %

+0.08 (+0.25%)

USD 0.04B
DVLU First Trust Dorsey Wright Mome.. 0.60 %

+0.06 (+0.21%)

USD 0.02B

ETFs Containing FAB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Value) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.01% 33% F 64% D
Dividend Return 0.31% 33% F 19% F
Total Return 5.32% 43% F 64% D
Trailing 12 Months  
Capital Gain 20.05% 50% F 73% C
Dividend Return 2.18% 33% F 33% F
Total Return 22.23% 50% F 74% C
Trailing 5 Years  
Capital Gain 52.13% 71% C- 73% C
Dividend Return 9.25% 29% F 37% F
Total Return 61.37% 57% F 73% C
Average Annual (5 Year Horizon)  
Capital Gain 10.58% 57% F 71% C-
Dividend Return 12.13% 71% C- 71% C-
Total Return 1.55% 43% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 27.01% 57% F 66% D+
Risk Adjusted Return 44.90% 71% C- 78% C+
Market Capitalization 0.11B 57% F 44% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.